Evidence map›Paper›PMID 24066737›Full record

ArticleAmerican journal of respiratory cell and molecular biology2014

Acute lung injury and fibrosis in a baboon model of Escherichia coli sepsis.

Ravi S Keshari, Robert Silasi-Mansat, Hua Zhu, Narcis I Popescu, Glenn Peer, Hala Chaaban, John D Lambris, Holly Polf, Cristina Lupu, Gary Kinasewitz and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04653831 (Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04653831 nacompletednot on this mapstarted 2020, after this paper: background citation

Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial

TypeinterventionalSponsorSoroka University Medical CenterRan2020 to 2022Enrolled26ConditionsCovid19, ARDSArmsPirfenidone, Standard of care
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Regulation of inflammatory lung injury and repair by transforming growth factors.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Mechanisms of Lung Fibrosis Resolution.The American journal of pathology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ravi S Keshari1 Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
Robert Silasi-Mansat
Hua Zhu
Narcis I Popescu
Glenn Peer
Hala Chaaban
John D Lambris
Holly Polf
Cristina Lupu
Gary Kinasewitz
Florea Lupu
Oklahoma Medical Research Foundation · USPulmonary and Critical Care Associates · USOklahoma State University · USPerinatal Institute · GBUniversity of Pennsylvania · US

Funding

Baboon Research Resource ProgramP40OD010988 · OD · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BANKS, RON E · 2012 to 2018
$9.0M
Complement inhibition as sepsis therapyR01GM097747 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LAMBRIS, JOHN D, LUPU, FLOREA · 2011 to 2014
$2.1M
NIGMS NIH HHS GM097747-01NIGMS NIH HHS R01 GM097747NIH HHS P40 OD010988
6 · The paper itself

Abstract

Sepsis-induced inflammation of the lung leads to acute respiratory distress syndrome (ARDS), which may trigger persistent fibrosis. The pathology of ARDS is complex and poorly understood, and the therapeutic approaches are limited. We used a baboon model of Escherichia coli sepsis that mimics the complexity of human disease to study the pathophysiology of ARDS. We performed extensive biochemical, histological, and functional analyses to characterize the disease progression and the long-term effects of sepsis on the lung structure and function. Similar to humans, sepsis-induced ARDS in baboons displays an early inflammatory exudative phase, with extensive necrosis. This is followed by a regenerative phase dominated by proliferation of type 2 epithelial cells, expression of epithelial-to-mesenchymal transition markers, myofibroblast migration and proliferation, and collagen synthesis. Baboons that survived sepsis showed persistent inflammation and collagen deposition 6-27 months after the acute episodes. Long-term survivors had almost double the amount of collagen in the lung as compared with age-matched control animals. Immunostaining for procollagens showed persistent active collagen synthesis within the fibroblastic foci and interalveolar septa. Fibroblasts expressed markers of transforming growth factor-β and platelet-derived growth factor signaling, suggesting their potential role as mediators of myofibroblast migration and proliferation, and collagen deposition. In parallel, up-regulation of the inhibitors of extracellular proteases supports a deregulated matrix remodeling that may contribute to fibrosis. The primate model of sepsis-induced ARDS mimics the disease progression in humans, including chronic inflammation and long-lasting fibrosis. This model helps our understanding of the pathophysiology of fibrosis and the testing of new therapies.

Indexed as

Escherichia coliAcute Lung InjuryAnimalsCollagenDisease Models, AnimalFibrosisHumansInflammationLungPapioRespiratory Distress SyndromeSepsisSignal TransductionTransforming Growth Factor betaCollagenTransforming Growth Factor beta

Identifiers

PMID24066737
PMCPMC3930952
OpenAlexW1940215786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.